AC-53-YM36_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, N-[1-(Cyanomethyl-carbamoyl)-cyclohexyl]-4-[1-(2-methoxy-ethyl)-piperidin-4-yl]-benzamide, Cathepsin K Inhibitors targeting CTSK (Novartis, 10202732)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10202732
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the AC-53-YM36_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GAPDH glyceraldehyde-3-phosphate dehydrogenase 1.04594
RHOG ras homolog family member G 0.962041
LBHD1 LBH domain containing 1 0.626104
MLF2 myeloid leukemia factor 2 0.416717
PHPT1 phosphohistidine phosphatase 1 0.402126
NDUFA3 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa 0.356291
NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) 0.342857
GRINA glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) 0.342857
RYR2 ryanodine receptor 2 (cardiac) 0.244874
SCAND1 SCAN domain containing 1 0.244874
NAA10 N(alpha)-acetyltransferase 10, NatA catalytic subunit 0.232758
LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) 0.224247
TPM2 tropomyosin 2 (beta) 0.222828